Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG^) closed at $0.14 on November 11, 2026, unchanged from the previous close, on volume of 56,778 shares (30-day average 17,548).
Data as of November 11, 2026.
No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of November 12, 2026, CELG^ stock price climbed to $0.18 with 47,909 million shares trading.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.27 and as low as $.02.
CELG^ has outperformed the market in the last year with a price return of +545.2% while the SPY ETF gained +12.8%. CELG^ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +93.1% and +63.6%, respectively, while the SPY returned -0.8% and -1.2%, respectively.
CELG^ support price is $.11 and resistance is $.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
